Systematic Review of Drug Eluting Balloon Angioplasty for Arteriovenous Haemodialysis access Stenosis
The Journal of Vascular Access2016Vol. 17(2), pp. 103–110
Citations Over TimeTop 1% of 2016 papers
Aurangzaib Khawaja, Deirdre Cassidy, Julien Al Shakarchi, Damian McGrogan, Nicholas Inston, Robert G. Jones
Abstract
Current literature reports DeBs as being safe and may convey some benefit in terms of improved rate of restenosis when used to treat AV access disease. However, this body of evidence is small and clinically heterogeneous. A large multicentre RCT may help to clarify the role of DeBs in the percutaneous treatment of AV HD access stenosis.
Related Papers
- Reduction of early elastic recoil by cutting balloon angioplasty as compared to conventional balloon angioplasty.(2002)
- → Immediate and late outcome of excimer laser and balloon coronary angioplasty: A quantitative angiographic comparison based on matched lesions(1995)11 cited
- → Experience with laser—assisted balloon angioplasty and a rotary angioplasty instrument: Lessons learned(1991)8 cited
- → Cutting Balloon Angioplasty for Ostial Lesions of the Left Anterior Descending Artery(2000)2 cited
- Effect on C-reactive protein,interleukin-6 and intercellular adhesion molecule-1pre-and post-cutting balloon angioplasty(2003)